More than 20 million people worldwide experience acute coronary syndrome (e.g., heart attack). It often occurs when a blood vessel supplying the heart is suddenly blocked due to high-risk plaques. Despite recent advances in cardiology, the accurate diagnosis of high-risk plaques before they become life-threatening remains a significant challenge. This is mainly because cardiologists do not have adequate tools that would provide them with cellular-level insights into plaque formation to understand and monitor disease progression.
Building on a series of Dr Jiawen Li's recent breakthroughs, which centre around the fabrication of 3D micro-printed imaging catheters with outstanding image quality, Dr Li will develop the world’s first cellular-resolution intravascular imaging catheter. It will provide in vivo histology-scale images of a plaque. Dr Li will use this tool to enable reliable detection of high-risk plaques in patients, and will incorporate it into standard clinical procedures, to help clinicians optimise therapeutic decision-making for each patient.
Last updated30 January 2024